Personal tools

MCL coexpression mm9:3014: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!7.24e-26!73;UBERON:0004121!3.49e-25!95;UBERON:0000924!3.49e-25!95;UBERON:0006601!3.49e-25!95;UBERON:0001016!3.51e-25!75;UBERON:0002346!1.06e-20!64;UBERON:0003075!1.06e-20!64;UBERON:0007284!1.06e-20!64;UBERON:0010371!1.07e-16!73;UBERON:0000073!1.98e-16!54;UBERON:0003056!8.84e-16!49;UBERON:0001049!1.60e-14!52;UBERON:0005068!1.60e-14!52;UBERON:0006241!1.60e-14!52;UBERON:0007135!1.60e-14!52;UBERON:0000955!3.60e-12!47;UBERON:0006238!3.60e-12!47;UBERON:0002616!1.41e-11!46;UBERON:0003080!1.84e-10!40;UBERON:0002780!7.07e-10!39;UBERON:0001890!7.07e-10!39;UBERON:0006240!7.07e-10!39;UBERON:0002020!1.06e-09!34;UBERON:0010314!1.57e-09!92;UBERON:0003528!2.74e-07!29;UBERON:0002791!2.74e-07!29;UBERON:0001893!2.74e-07!29;UBERON:0000970!4.83e-07!9;UBERON:0000019!4.83e-07!9;UBERON:0000047!4.83e-07!9;UBERON:0010312!4.83e-07!9;UBERON:0004088!4.83e-07!9;UBERON:0002104!4.83e-07!9;UBERON:0001456!4.83e-07!9;UBERON:0003072!4.83e-07!9;UBERON:0004128!4.83e-07!9;UBERON:0003071!4.83e-07!9
|ontology_enrichment_uberon=UBERON:0001017!7.24e-26!73;UBERON:0004121!3.49e-25!95;UBERON:0000924!3.49e-25!95;UBERON:0006601!3.49e-25!95;UBERON:0001016!3.51e-25!75;UBERON:0002346!1.06e-20!64;UBERON:0003075!1.06e-20!64;UBERON:0007284!1.06e-20!64;UBERON:0010371!1.07e-16!73;UBERON:0000073!1.98e-16!54;UBERON:0003056!8.84e-16!49;UBERON:0001049!1.60e-14!52;UBERON:0005068!1.60e-14!52;UBERON:0006241!1.60e-14!52;UBERON:0007135!1.60e-14!52;UBERON:0000955!3.60e-12!47;UBERON:0006238!3.60e-12!47;UBERON:0002616!1.41e-11!46;UBERON:0003080!1.84e-10!40;UBERON:0002780!7.07e-10!39;UBERON:0001890!7.07e-10!39;UBERON:0006240!7.07e-10!39;UBERON:0002020!1.06e-09!34;UBERON:0010314!1.57e-09!92;UBERON:0003528!2.74e-07!29;UBERON:0002791!2.74e-07!29;UBERON:0001893!2.74e-07!29;UBERON:0000970!4.83e-07!9;UBERON:0000019!4.83e-07!9;UBERON:0000047!4.83e-07!9;UBERON:0010312!4.83e-07!9;UBERON:0004088!4.83e-07!9;UBERON:0002104!4.83e-07!9;UBERON:0001456!4.83e-07!9;UBERON:0003072!4.83e-07!9;UBERON:0004128!4.83e-07!9;UBERON:0003071!4.83e-07!9
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,1.23467,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.876292,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,1.1146,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,0.872889,0.563758,0.902078,1.32715,0.50014,0.582863,0.831295,0.724277,1.48356,1.47707,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.971403,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,1.62246,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,1.26911,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.212464,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,4.82049,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,2.65814,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.135528
}}
}}

Revision as of 22:17, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr15:84276967..84277011,-p1@1810041L15Rik
Mm9::chr15:84277449..84277464,-p5@1810041L15Rik
Mm9::chr15:84277467..84277495,-p3@1810041L15Rik


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system7.24e-2673
ectoderm-derived structure3.49e-2595
ectoderm3.49e-2595
presumptive ectoderm3.49e-2595
nervous system3.51e-2575
neurectoderm1.06e-2064
neural plate1.06e-2064
presumptive neural plate1.06e-2064
ecto-epithelium1.07e-1673
regional part of nervous system1.98e-1654
pre-chordal neural plate8.84e-1649
neural tube1.60e-1452
neural rod1.60e-1452
future spinal cord1.60e-1452
neural keel1.60e-1452
brain3.60e-1247
future brain3.60e-1247
regional part of brain1.41e-1146
anterior neural tube1.84e-1040
regional part of forebrain7.07e-1039
forebrain7.07e-1039
future forebrain7.07e-1039
gray matter1.06e-0934
structure with developmental contribution from neural crest1.57e-0992
brain grey matter2.74e-0729
regional part of telencephalon2.74e-0729
telencephalon2.74e-0729
eye4.83e-079
camera-type eye4.83e-079
simple eye4.83e-079
immature eye4.83e-079
ocular region4.83e-079
visual system4.83e-079
face4.83e-079
optic cup4.83e-079
optic vesicle4.83e-079
eye primordium4.83e-079


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}